Pierre Fabre Participations has appointed Hervé Hoppenot as Chairman of the Board of Directors of Pierre Fabre SA, an appointment approved by the Board at its meeting on May 21. This decision is accompanied by the appointment of Roch Doliveux as Vice-Chairman.
Hervé Hoppenot has been appointed Chairman of the Board of Directors of Pierre Fabre SA, a decision endorsed by the Board of Directors on May 21. A director since January 15, 2024, he succeeds Roch Doliveux, now Vice-Chairman.
Executive career and mandates held
Hervé Hoppenot, 65, a dual French-American citizen, led biotech Incyte as president and CEO from 2014 to 2025. He was also President of Novartis' global oncology franchise. In parallel with his new role at Pierre Fabre, he chairs the board of Maze Therapeutics and sits on the boards of Bicycle Therapeutics and N-Power Medicine.
Group succession and governance
Pierre Fabre Participations, the Group's controlling holding company, made the appointment. Pierre Yves Revol, Chairman of Pierre Fabre Participations, comments on the succession between Roch Doliveux and Hervé Hoppenot, recalling the 2017-2026 period covered by the previous chairmanship.
Hervé Hoppenot declared: «I'm very happy to bring my expertise to an independent group, strongly rooted in its territory and a major player in the health and beauty sector. It's an honor for me to have the opportunity to help Group CEO Eric Ducournau to develop the business as he has been doing since 2019, and to contribute to the development of a highly virtuous group, owned by a Foundation recognized as being in the public interest, the recipient of profits distributed by the company to develop action programs for the benefit of the most disadvantaged in terms of healthcare in the least favored countries.».
Sophie Le Tanneur joins the Board of Directors of Pierre Fabre SA as a Director; she also sits on the Boards of Groupe Bollinger and CIS Catering.
The next institutional milestone mentioned is the continuity of the executive mandate, with Eric Ducournau in post as CEO from 2019.
